INS and epilepsy: This was also the case for most described patients with YIPF5-MEDS; however, a recent report described an individual with a homozygous YIPF5 missense variant who, in addition to microcephaly and epilepsy, had illness-induced hyperglycemia (42), with no insulin requirement between episodes.